Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (103)	1/1/2000 9:46:00 PM
From: Mike McFarland	Respond to of 360

Froth? Judging only from the way glgc took off all at once at the beginning of December and the half a billion dollar marketcap, well, I would just suggest that there might be cheaper plays in genomics out there--but for all I know Gene Logic is worth a billion--and they are all still undervalued. You know my picks, we will just have to see what 2000 brings for the rest of the sector, maybe Celera will just buy everybody out, heheh--now that is frothy good beer! It was interesting that the rise in glgc shares roughly coincides with that Robbie Stephens' Medical Conference, so somebody sure liked something the company had to say. I've not even read that Wall Street transcript interview so I'll quit now before I say something lame--I'd be happy enough if the froth spilled over and prevented AXPH from hitting my stop.